medroxyprogesterone acetate has been researched along with Blood Clot in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boesch, C; Bronner, C; Hecker, M; Jourdain, M; Schini-Kerth, VB; Zerr-Fouineau, M | 1 |
| Allison, M; Anderson, GL; Brzyski, R; Jackson, RD; Johnson, KC; Kuller, LH; Lane, DS; Langer, RD; Manson, JE; Ockene, J; Pettinger, M; Prentice, RL; Rossouw, JE; Sarto, G; Wactawski-Wende, J | 1 |
| Fischer, JW; Freudenberger, T; Heim, HK; Kojda, G; Marzoll, A; Mayer, P; Oppermann, M; Schrör, K; Weber, AA | 1 |
| Wallis, L | 1 |
| Anderson, GL; Beresford, SA; Howard, BV; Jackson, RD; Johnson, KC; Kooperberg, C; Kotchen, JM; LaCroix, AZ; Ockene, J; Prentice, RL; Rossouw, JE; Stefanick, ML | 1 |
| Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO | 1 |
| Heinemann, V; Parhofer, K | 1 |
| Danby, FW | 1 |
| Mizuuchi, H; Mori, Y; Okamura, N; Sato, K | 1 |
| Kanoh, H; Okudaira, Y | 1 |
| Adams, MR; Bellinger, DA; Bender, DE; Honoré, EK; Williams, JK | 1 |
| Anan, K; Mitsuyama, S | 1 |
| Furusawa, A; Momono, S; Nakagawa, K; Sasaki, Y; Sato, T; Toshima, T | 1 |
| Allam, G; Alloush, M; Fahmy, K; Gobran, F; Khairy, M | 1 |
| Hosono, T; Kanoh, H; Matsui, Y; Okudaira, Y | 1 |
3 review(s) available for medroxyprogesterone acetate and Blood Clot
| Article | Year |
|---|---|
[Hormonal therapy in endometrial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Medroxyprogesterone Acetate; Tamoxifen; Thrombosis; Uterine Neoplasms | 1993 |
[Medroxyprogesterone acetate for treatment of advanced breast cancers].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Medroxyprogesterone Acetate; Quality of Life; Thrombosis | 2000 |
[Growth of endometrial cancer and hormone].
Topics: Aged; Antineoplastic Agents; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Thrombosis; Uterine Neoplasms | 1989 |
4 trial(s) available for medroxyprogesterone acetate and Blood Clot
| Article | Year |
|---|---|
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Contraceptive Agents, Female; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progestins; Pulmonary Embolism; Retrospective Studies; Risk Factors; Stroke; Survival Rate; Thrombosis; Time Factors; Washington | 2009 |
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Topics: Aged; Breast Neoplasms; Clinical Trials Data Monitoring Committees; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk; Stroke; Survival Analysis; Thrombosis; Treatment Outcome | 2002 |
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus | 2002 |
[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study].
Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk Assessment; Stroke; Survival Analysis; Thrombosis; Treatment Outcome; United States; Women's Health | 2003 |
9 other study(ies) available for medroxyprogesterone acetate and Blood Clot
| Article | Year |
|---|---|
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Topics: Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; GTP Cyclohydrolase; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Norpregnadienes; Platelet Aggregation; Progesterone; Progesterone Congeners; Pterins; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Thrombosis; Time Factors | 2009 |
Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice.
Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogens; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Ovariectomy; Platelet Activation; Thrombin; Thrombosis | 2009 |
Beyond politics: new medical concerns for contraceptive users.
Topics: Administration, Cutaneous; Adult; Androstenes; Breast Neoplasms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Mineralocorticoid Receptor Antagonists; Thrombosis; United States | 2012 |
Postmenopausal hormone therapy offers no protection against heart attacks.
Topics: Aged; Controlled Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gallbladder Diseases; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Placebos; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors; Thrombosis; Time Factors | 2002 |
HT and WHI: the baby and the bathwater.
Topics: Blood Coagulation Factors; Breast Neoplasms; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone Acetate; Mutation; Progesterone; Thrombosis | 2004 |
[A report of two endometrial cancer cases in that low-dose aspirin was effective for hypercoagulopathy caused by medroxyprogesterone acetate].
Topics: Adenocarcinoma; Adult; Aspirin; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Thrombosis | 1995 |
Oral contraceptives and hormone replacement therapy do not increase the incidence of arterial thrombosis in a nonhuman primate model.
Topics: Animals; Carotid Artery Thrombosis; Carotid Stenosis; Contraceptives, Oral; Diet, Atherogenic; Estrogen Replacement Therapy; Estrogens; Female; Hemodynamics; Immunohistochemistry; Lipoprotein(a); Macaca fascicularis; Medroxyprogesterone Acetate; Postmenopause; Premenopause; Protein C; Thrombosis; von Willebrand Factor | 1998 |
[A case of jejunal vein thrombosis due to medroxyprogesterone acetate].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Jejunum; Medroxyprogesterone Acetate; Thrombosis; Veins | 1992 |
Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women.
Topics: Adult; Antithrombin III; Arteriosclerosis; Blood Coagulation Factors; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Egypt; Female; Humans; Lipids; Longitudinal Studies; Medroxyprogesterone; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Thrombosis; Time Factors; Triglycerides | 1991 |